Company: CNTB
Filing Date: 2025-04-01
Form Type: 8-K
Source: 0001835268-25-000019
Chunk: 2

Company: Connect Biopharma Holdings Ltd
Filing Date: 2025-04-01
Form: 8-K
Item: Item 8.01
Chunk 2
---
 due to geopolitical changes or other external factors; and unexpected litigation or other disputes. Drug development and commercialization involve a high degree of risk, and only a small number of research and development programs result in commercialization of a product. Results in early-stage clinical trials may not be indicative of full results or results from later stage or larger scale clinical trials and do not ensure regulatory approval. You should not place undue reliance on these statements, or the scientific data presented. Other factors that may cause actual results to differ from those expressed or implied in the forward-looking statements herein are discussed in the Company’s filings with the U. S. Securities and Exchange Commission, including the section titled “ Risk Factors” contained therein, including in our annual report on Form 10-K for the year ended December 31, 2024, and any subsequent filings with the SEC. Except as required by law, the Company assumes no obligation to update any forward-looking statements contained herein to reflect any change in expectations, even as new information becomes available.

Item 9.01 Financial Statements and Exhibits.